On blue­bird's heels, CRISPR Ther­a­peu­tics and Ver­tex take the air with in­ter­im CRISPR blood cell ther­a­py da­ta

3 weeks ago
R&D

Genen­tech cam­paign aims to in­crease cys­tic fi­bro­sis aware­ness among Lati­no com­mu­ni­ty and health­care providers

3 weeks ago
Pharma
Marketing

CSL Behring teams with fa­mous pho­tog­ra­ph­er to fo­cus on he­mo­phil­ia for art ex­hib­it and on­line gallery cam­paign

3 weeks ago
R&D

Bio­gen yanks its Aduhelm ap­pli­ca­tion in Cana­da, days af­ter cel­e­brat­ing the drug's 1-year an­niver­sary in the US

3 weeks ago
Pharma

Broad In­sti­tute's drug dis­cov­ery arm starts see­ing the fruit of its la­bor en­ter the clin­ic

3 weeks ago
R&D

Psy­che­delics start­up Eleu­sis ax­es SPAC deal, but CEO con­fi­dent its IV psilo­cy­bin ther­a­py will en­ter clin­ic next month

3 weeks ago
Financing
Deals

GSK de­clares a big win with pos­i­tive topline re­sults for its adult RSV vac­cine. But the ju­ry's still out on bot­tom line ef­fi­ca­cy

3 weeks ago
R&D

#BIO22 sur­vey: The E100 as­sess the Nas­daq win­ter that is freez­ing out biotech. But hir­ing re­mains a top pri­or­i­ty

3 weeks ago
R&D

#BIO22: The bear mar­ket may be maul­ing biotech stocks, but the fun­da­men­tals still look good to re­al es­tate de­vel­op­ers

3 weeks ago
Financing
Deals

#BIO22: Are biotech buy­outs fi­nal­ly com­ing in­to vogue? Here's what to look for in H2 M&A

3 weeks ago
Financing
Deals

Roche's ROS1+ can­cer drug gets FDA green­light for Foun­da­tion Med­i­cine's com­pan­ion di­ag­nos­tic

3 weeks ago
Pharma
Diagnostics

CDC writes first check in $1.1B Can­cer Moon­shot grant

3 weeks ago
Pharma

J&J ad­vances ‘Pos­i­tive­ly Fear­less’ HIV cam­paign, de­but­ing web­site and newest am­bas­sador

3 weeks ago
Pharma
Marketing

#BIO22: BIO chair Paul Hast­ings: 'I think peo­ple should speak their truth'

3 weeks ago
People
R&D

#BIO22: Com­ing to­geth­er at a crit­i­cal time, End­points News looks at the key met­rics on bio­phar­ma in a tur­bu­lent time

3 weeks ago
Bioregnum

Sen­ti Bio com­pletes its SPAC merg­er, though not be­fore see­ing in­vestors 'play­ing a fi­nan­cial game'

3 weeks ago
Financing

Dur­ing tepid pub­lic mar­ket, Biospring clos­es quar­ter bil­lion dol­lar man­u­fac­tur­ing and tech-fo­cused fund

3 weeks ago
Financing

House pass­es bi­par­ti­san FDA user fee leg­is­la­tion as it aligns with Sen­ate on ac­cel­er­at­ed ap­proval re­forms

3 weeks ago
FDA+

With deep ties to Bay­lor and fresh sup­port from Po­laris, Sin­ga­pore's Tes­sa rais­es $126M for piv­otal CAR study

3 weeks ago
Financing
Cell/Gene Tx

Har­vard, Kessel­heim pa­per high­lights al­most 90x in­crease in launch prices for new drugs since 2008

3 weeks ago
Pharma

IPG Health launch­es 90North agency with bio­phar­ma fu­ture look

3 weeks ago
Pharma
Marketing

WTO ap­proach­es a deal ear­ly next week for a Covid-19 vac­cine IP waiv­er

3 weeks ago
Pharma
Coronavirus

RA Cap­i­tal backs a Philly biotech's $118M crossover as it aims to break in­to the hy­per­ten­sion space

3 weeks ago
Financing
Startups

Mod­er­na says Omi­cron-spe­cif­ic boost­er bet­ter than cur­rent shot, aims for late sum­mer ap­proval

3 weeks ago
Coronavirus
First page Previous page 1234567 Next page Last page